The Chemours Company
CC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $5,782,000 | $6,078,000 | $6,831,000 | $6,345,000 |
| % Growth | -4.9% | -11% | 7.7% | – |
| Cost of Goods Sold | $4,631,000 | $4,772,000 | $5,215,000 | $4,964,000 |
| Gross Profit | $1,151,000 | $1,306,000 | $1,616,000 | $1,381,000 |
| % Margin | 19.9% | 21.5% | 23.7% | 21.8% |
| R&D Expenses | $109,000 | $108,000 | $118,000 | $107,000 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $585,000 | $1,290,000 | $710,000 | $592,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $14,000 | $31,000 | $2,000 | $8,000 |
| Operating Expenses | $708,000 | $1,429,000 | $830,000 | $707,000 |
| Operating Income | $443,000 | -$123,000 | $786,000 | $674,000 |
| % Margin | 7.7% | -2% | 11.5% | 10.6% |
| Other Income/Exp. Net | -$316,000 | -$195,000 | -$45,000 | $2,000 |
| Pre-Tax Income | $127,000 | -$318,000 | $741,000 | $676,000 |
| Tax Expense | $41,000 | -$81,000 | $163,000 | $68,000 |
| Net Income | $86,000 | -$238,000 | $578,000 | $608,000 |
| % Margin | 1.5% | -3.9% | 8.5% | 9.6% |
| EPS | 0.58 | -1.6 | 3.72 | 3.69 |
| % Growth | 136.3% | -143% | 0.8% | – |
| EPS Diluted | 0.57 | -1.6 | 3.65 | 3.6 |
| Weighted Avg Shares Out | 149,494 | 148,912 | 155,359 | 164,944 |
| Weighted Avg Shares Out Dil | 150,014 | 148,912 | 158,303 | 168,698 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $264,000 | $208,000 | $163,000 | $185,000 |
| Depreciation & Amortization | $301,000 | $307,000 | $291,000 | $317,000 |
| EBITDA | $692,000 | $197,000 | $1,195,000 | $1,178,000 |
| % Margin | 12% | 3.2% | 17.5% | 18.6% |